Patents by Inventor Noriyuki Fujikado

Noriyuki Fujikado has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210040218
    Abstract: An object of the present invention is to find a ligand for a DCIR and to search for an agonist and an antagonist for the DCIR. Specifically, disclosed are: a dendritic cell immunoreceptor agonist containing keratan sulfate-II (KS-II) as an active ingredient; an antibody against dendritic cell immunoreceptor, having a keratan sulfate-II-like dendritic cell immunoreceptor agonism; and an antibody against a dendritic cell immunoreceptor, having a keratan sulfate-II inhibitory dendritic cell immunoreceptor antagonism.
    Type: Application
    Filed: August 12, 2020
    Publication date: February 11, 2021
    Applicant: TOKYO UNIVERSITY OF SCIENCE FOUNDATION
    Inventors: Yoichiro IWAKURA, Noriyuki Fujikado, Guangyu Ma
  • Publication number: 20130058957
    Abstract: An object of the present invention is to find a ligand for a DCIR and to search for an agonist and an antagonist for the DCIR. Specifically, disclosed are: a dendritic cell immunoreceptor agonist containing keratan sulfate-II (KS-II) as an active ingredient; an antibody against dendritic cell immunoreceptor, having a keratan sulfate-II-like dendritic cell immunoreceptor agonism; and an antibody against a dendritic cell immunoreceptor, having a keratan sulfate-II inhibitory dendritic cell immunoreceptor antagonism.
    Type: Application
    Filed: February 23, 2011
    Publication date: March 7, 2013
    Applicant: THE UNIVERSITY OF TOKYO
    Inventors: Yoichiro Iwakura, Noriyuki Fujikado, Guangyu Ma
  • Publication number: 20090202440
    Abstract: It is intended to disclose the function of dendritic cell immunoreceptor (DCIR) and clarify its role in the onset of autoimmune arthritis. It is also intended to provide a method of screening a substance which is useful in treating/preventing an autoimmune disease or osteoporosis. A nonhuman disease model animal characterized by having a partial or entire deficiency of a gene encoding the DCIR protein on the chromosome; a method of screening a substance which is useful in treating/preventing a DCIR-related disease, for example, an autoimmune disease such as arthropathy by using the nonhuman disease model animal as described above; and a remedy/preventive therefor.
    Type: Application
    Filed: June 26, 2007
    Publication date: August 13, 2009
    Inventors: Yoichiro Iwakura, Shinobu Saijo, Noriyuki Fujikado